Developer docs
API playgroundTry for free, no card

Search company profiles

Genlantis

Full company profile

uuid002ojy2

Namestring
Genlantis
Legal namestring
Genlantis Inc.
Websiteurl
genlantis.com
Company typeenum
Private
Founded yearint
1998
Short descriptiontext

Genlantis, a San Diego life sciences firm founded in 1998, designs and supplies biological reagents and specialty products spanning transfection, cell culture, RNAi, competent cells, expression systems, and proteomics for academic and biotech research laboratories; since 2023 it has operated as a product line under AMSBIO distribution.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
transfection reagents, cell culture media, molecular biology products, life science reagents, RNAi products
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Life Science Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Reagents & Media Sales
TypeOne Time License
Description

Sale of transfection reagents, cell culture media, RNAi products, competent cells, and proteomics reagents to research laboratories and biotechnology companies. Products are sold as catalog items through distribution channels including AMSBIO following acquisition.

genlantis.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Pricing details1 tier
1Catalog research reagents
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Standard catalog pricing for research reagents and cell culture products. Specific prices available through AMSBIO ordering system.

genlantis.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Genlantis designs and develops biological reagents and specialty life science systems, supplying molecular biology products including transfection reagents (DNA, siRNA, neuronal, protein, insect), cell culture media and reagents, species-specific cell lines, RNAi siRNA generation kits, competent cells, protein expression systems, and proteomics tools. The company sells its product catalog to research laboratories and biotechnology firms, with distribution now handled by parent company AMSBIO following a 2023 acquisition.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Transfection Reagents
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AMSBIO acquired Genlantis and now distributes the complete Genlantis product line including transfection reagents, cell culture media, RNAi products, and proteomics reagents. The acquisition enables continued customer access to Genlantis products through AMSBIO's established distribution channels.

Peers10 records
TypeBroad incumbent
Description

Major supplier of cell culture media and bioprocessing reagents, competing with Genlantis in the Cells & Media category particularly for biopharma customers.

TypeOthers
Description

Acquired Genlantis in 2023 and now distributes the product line; AMSBIO itself supplies a broad catalog of life science reagents and cell culture products that includes Genlantis as a brand, making it both parent and channel-adjacent peer.

TypeBroad incumbent
Description

Supplies molecular biology reagents, competent cells, and protein analysis tools that compete with Genlantis's COMP CELLS/EXPRESSION and Proteomics lines.

TypeDirect peer
Description

Producer of transfection reagents and specialty biomaterials for molecular and cell biology research, comparable in product mix and customer base to Genlantis.

5Takara Bio
TypeDirect peer
Description

Provides molecular biology reagents including competent cells, RNAi tools, and cell culture products, overlapping heavily with Genlantis's competent cells, RNAi, and protein expression lines.

TypeDirect peer
Description

Supplies cell culture media, reagents, and stem cell products to academic and biopharma researchers — directly comparable to Genlantis's Cells & Media and stem cell offerings.

7Corning Life Sciences
TypeBroad incumbent
Description

Provides cell culture media and consumables used in research and bioprocessing workflows, directly comparable to Genlantis's Cell Culture Media offerings.

TypeBroad incumbent
Description

Dominant broad-line supplier of transfection reagents (Lipofectamine), cell culture media, and RNAi tools through its Life Sciences/Invitrogen portfolio — competes across every Genlantis category.

9MilliporeSigma (Life Science)
TypeBroad incumbent
Description

Sells transfection reagents (CalPhos), cell culture media, and a comprehensive catalog of molecular biology reagents overlapping with Genlantis's full product line.

TypeDirect peer
Description

Specialist manufacturer of transfection reagents (DNA, siRNA, mRNA, protein delivery) for research and bioprocessing, directly overlapping Genlantis's core transfection product line.

Market position
Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genlantis

Life Science Reagentsgenlantis.com

Genlantis, a San Diego life sciences firm founded in 1998, designs and supplies biological reagents and specialty products spanning transfection, cell culture, RNAi, competent cells, expression systems, and proteomics for academic and biotech research laboratories; since 2023 it has operated as a product line under AMSBIO distribution.

Genlantis firmographics

Firmographics
Name
Genlantis
Legal name
Genlantis Inc.
Website
https://genlantis.com
Company type
Private
Founded year
1998
Operating status
Acquired
Headcount range
11–50 employees
Short description
Genlantis, a San Diego life sciences firm founded in 1998, designs and supplies biological reagents and specialty products spanning transfection, cell culture, RNAi, competent cells, expression systems, and proteomics for academic and biotech research laboratories; since 2023 it has operated as a product line under AMSBIO distribution.
Ownership category
akta.pro rank

Where Genlantis is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

Genlantis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Revenue model

  1. Research Reagents & Media Sales: Sale of transfection reagents, cell culture media, RNAi products, competent cells, and proteomics reagents to research laboratories and biotechnology companies. Products are sold as catalog items through distribution channels including AMSBIO following acquisition.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCatalog research reagents

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Genlantis product offering

Product offering

Core offering

Genlantis designs and develops biological reagents and specialty life science systems, supplying molecular biology products including transfection reagents (DNA, siRNA, neuronal, protein, insect), cell culture media and reagents, species-specific cell lines, RNAi siRNA generation kits, competent cells, protein expression systems, and proteomics tools. The company sells its product catalog to research laboratories and biotechnology firms, with distribution now handled by parent company AMSBIO following a 2023 acquisition.

Differentiator

Problem solved

Functional benefit

Products and services

  • Transfection Reagents

Companies that use Genlantis

Customer profile

Segments3 records

Ideal customer profiles3 records

Genlantis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Genlantis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AMSBIOcoreChannel Partner/ Reseller/ DistributorAMSBIO acquired Genlantis and now distributes the complete Genlantis product line including transfection reagents, cell culture media, RNAi products, and proteomics reagents. The acquisition enables continued customer access to Genlantis products through AMSBIO's established distribution channels.

Scale indicators1 record

Genlantis competitors and assessment

Company assessment

Broad incumbents

  • Lonza Bioscience: Major supplier of cell culture media and bioprocessing reagents, competing with Genlantis in the Cells & Media category particularly for biopharma customers.
  • Bio-Rad Laboratories: Supplies molecular biology reagents, competent cells, and protein analysis tools that compete with Genlantis's COMP CELLS/EXPRESSION and Proteomics lines.
  • Corning Life Sciences: Provides cell culture media and consumables used in research and bioprocessing workflows, directly comparable to Genlantis's Cell Culture Media offerings.
  • Thermo Fisher Scientific (Life Sciences): Dominant broad-line supplier of transfection reagents (Lipofectamine), cell culture media, and RNAi tools through its Life Sciences/Invitrogen portfolio — competes across every Genlantis category.
  • MilliporeSigma (Life Science): Sells transfection reagents (CalPhos), cell culture media, and a comprehensive catalog of molecular biology reagents overlapping with Genlantis's full product line.

Others

  • AMSBIO: Acquired Genlantis in 2023 and now distributes the product line; AMSBIO itself supplies a broad catalog of life science reagents and cell culture products that includes Genlantis as a brand, making it both parent and channel-adjacent peer.

Direct peers

  • Polysciences: Producer of transfection reagents and specialty biomaterials for molecular and cell biology research, comparable in product mix and customer base to Genlantis.
  • Takara Bio: Provides molecular biology reagents including competent cells, RNAi tools, and cell culture products, overlapping heavily with Genlantis's competent cells, RNAi, and protein expression lines.
  • STEMCELL Technologies: Supplies cell culture media, reagents, and stem cell products to academic and biopharma researchers — directly comparable to Genlantis's Cells & Media and stem cell offerings.
  • Mirus Bio: Specialist manufacturer of transfection reagents (DNA, siRNA, mRNA, protein delivery) for research and bioprocessing, directly overlapping Genlantis's core transfection product line.

Market position

Customer concentration

Genlantis social profiles

Digital presence

Genlantis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genlantis leadership team

Management profile

Number of profiles

Genlantis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genlantis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genlantis

What does Genlantis do?

Genlantis designs and develops biological reagents and specialty life science systems, supplying molecular biology products including transfection reagents (DNA, siRNA, neuronal, protein, insect), cell culture media and reagents, species-specific cell lines, RNAi siRNA generation kits, competent cells, protein expression systems, and proteomics tools. The company sells its product catalog to research laboratories and biotechnology firms, with distribution now handled by parent company AMSBIO following a 2023 acquisition.

Is Genlantis a public or private company?

Genlantis is a private company. It is classified as corporate owned and is currently acquired.

When was Genlantis founded?

Genlantis was founded in 1998. It employs 11 to 50 people.

Where is Genlantis based?

Genlantis is headquartered in San Diego, United States, in the North America region.

How does Genlantis make money?

One revenue line is on record: research Reagents & Media Sales.

Who are Genlantis's main competitors?

Broad incumbents on record are Lonza Bioscience, Bio-Rad Laboratories, Corning Life Sciences, Thermo Fisher Scientific (Life Sciences) and MilliporeSigma (Life Science). AMSBIO is listed as an others. Direct peers are Polysciences, Takara Bio, STEMCELL Technologies and Mirus Bio.

Does Genlantis have an API?

No public API is recorded for Genlantis.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales